About this document
Defining Acquired Resistance in NSCLC by roynel969 is a document available to read on EtoBox.
The article discusses the clinical definition of acquired resistance (AR) to PD-(L)1 blockade in patients with metastatic non-small-cell lung cancer (NSCLC), emphasizing the need for a standardized definition to facilitate clinical trials and therapeutic advancements. It proposes specific criteria for identifying AR, including prior treatment with PD-(L)1 blockade, objective response, and timing of disease progression. The authors highlight the importance of distinguishing AR from primary resistance to impr
- Author
- roynel969
- Language
- EN